REFERENCES
- Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: A meta-analysis of prevalence and risk factors. Clin Infect Dis 2003; 36: 131–9.
- National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests: Approved standard. Wayne, PA:NCCLS, 2002; docu-ment M2-A6.
- Comite de L'antibiogramme de la Societe Francaise de Microbiologie. Communique Path Biol 1996; 44: 1.
- Coutant C, Olden D, Bell J, Turnidge JD. Disk diffusion interpretive criteria for fusidic acid susceptibility testing of staphylococci by the National Committee for Clinical Laboratory Standards method. Diagn Microbiol Infect Dis 1996; 25: 9–13.
- Nishijima S, Kurokawa I, Nakaya H. Susceptibility change to antibiotics of Staphylococcus aureus strains isolated from skin infections between 1994 and 2000. J Infect Chemother 2002; 8: 187–9.
- Chang SC, Hsieh SM, Chen ML, Sheng WH, Chen YC. Oral fusidic acid fails to eradicate methicillin-resistant Staphylococcus aureus colonization and results in emergence of fusidic acid-resistant strains. Diagn Microbiol Infect Dis 2000; 36: 131–6.
- Mandell LA. Fusidic acid. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone Inc, 2000: 306–7.
- Drancourt M, Stein A, Argenson JN, Roiron R, Groulier P, Raoult D. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combina-tion with rifampicin. J Antimicrob Chemother 1997; 39: 235–40.
- Turkisher V, Priel I, Dan M. Successful management of an infected implantable cardioverter defibrillator with oral antibiotics and without removal of the device. PACE 1997; 20: 2268–70.